0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Injectable Pain Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: December 2024
|
Report Code: QYRE-Auto-33W5690
Home | Market Reports | Health| Health Conditions| Pain Management
Global Injectable Pain Medication Market Insights and Forecast to 2028
BUY CHAPTERS

Injectable Pain Medication - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-33W5690
Report
December 2024
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Injectable Pain Medication - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Injectable Pain Medication - Market

Injectable Pain Medication - Market

Analgesics refer to drugs that can partially or completely relieve pain. There are two types of non-steroidal anti-inflammatory drugs and central analgesics. The latter is currently mainly used in the treatment of cancer pain, and can also be used for short-term postoperative pain relief.
The global market for Injectable Pain Medication was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Injectable Pain Medication, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Injectable Pain Medication by region & country, by Type, and by Application.
The Injectable Pain Medication market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Pain Medication.
Market Segmentation

Scope of Injectable Pain Medication - Market Report

Report Metric Details
Report Name Injectable Pain Medication - Market
CAGR 5%
Segment by Type:
  • Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
  • Central Analgesics
Segment by Application
  • Hospital
  • Clinics
  • Recovery Center
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company GlaxoSmithKline, Merck, Pfizer, Novartis, Sanofi, Bayer, Johson & Johson, Boehringer Ingelheim, Sun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Injectable Pain Medication manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Revenue of Injectable Pain Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Revenue of Injectable Pain Medication in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Injectable Pain Medication - Market report?

Ans: The main players in the Injectable Pain Medication - Market are GlaxoSmithKline, Merck, Pfizer, Novartis, Sanofi, Bayer, Johson & Johson, Boehringer Ingelheim, Sun Pharmaceutical

What are the Application segmentation covered in the Injectable Pain Medication - Market report?

Ans: The Applications covered in the Injectable Pain Medication - Market report are Hospital, Clinics, Recovery Center

What are the Type segmentation covered in the Injectable Pain Medication - Market report?

Ans: The Types covered in the Injectable Pain Medication - Market report are Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Central Analgesics

Recommended Reports

Pain and Analgesics

Injectable Drug Delivery

Chronic and Neuropathic Pain

1 Market Overview
1.1 Injectable Pain Medication Product Introduction
1.2 Global Injectable Pain Medication Market Size Forecast
1.3 Injectable Pain Medication Market Trends & Drivers
1.3.1 Injectable Pain Medication Industry Trends
1.3.2 Injectable Pain Medication Market Drivers & Opportunity
1.3.3 Injectable Pain Medication Market Challenges
1.3.4 Injectable Pain Medication Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Injectable Pain Medication Players Revenue Ranking (2023)
2.2 Global Injectable Pain Medication Revenue by Company (2019-2024)
2.3 Key Companies Injectable Pain Medication Manufacturing Base Distribution and Headquarters
2.4 Key Companies Injectable Pain Medication Product Offered
2.5 Key Companies Time to Begin Mass Production of Injectable Pain Medication
2.6 Injectable Pain Medication Market Competitive Analysis
2.6.1 Injectable Pain Medication Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Injectable Pain Medication Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Pain Medication as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
3.1.2 Central Analgesics
3.2 Global Injectable Pain Medication Sales Value by Type
3.2.1 Global Injectable Pain Medication Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Injectable Pain Medication Sales Value, by Type (2019-2030)
3.2.3 Global Injectable Pain Medication Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinics
4.1.3 Recovery Center
4.2 Global Injectable Pain Medication Sales Value by Application
4.2.1 Global Injectable Pain Medication Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Injectable Pain Medication Sales Value, by Application (2019-2030)
4.2.3 Global Injectable Pain Medication Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Injectable Pain Medication Sales Value by Region
5.1.1 Global Injectable Pain Medication Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Injectable Pain Medication Sales Value by Region (2019-2024)
5.1.3 Global Injectable Pain Medication Sales Value by Region (2025-2030)
5.1.4 Global Injectable Pain Medication Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Injectable Pain Medication Sales Value, 2019-2030
5.2.2 North America Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Injectable Pain Medication Sales Value, 2019-2030
5.3.2 Europe Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Injectable Pain Medication Sales Value, 2019-2030
5.4.2 Asia Pacific Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Injectable Pain Medication Sales Value, 2019-2030
5.5.2 South America Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Injectable Pain Medication Sales Value, 2019-2030
5.6.2 Middle East & Africa Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Injectable Pain Medication Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Injectable Pain Medication Sales Value
6.3 United States
6.3.1 United States Injectable Pain Medication Sales Value, 2019-2030
6.3.2 United States Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Injectable Pain Medication Sales Value, 2019-2030
6.4.2 Europe Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Injectable Pain Medication Sales Value, 2019-2030
6.5.2 China Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.5.3 China Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Injectable Pain Medication Sales Value, 2019-2030
6.6.2 Japan Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Injectable Pain Medication Sales Value, 2019-2030
6.7.2 South Korea Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Injectable Pain Medication Sales Value, 2019-2030
6.8.2 Southeast Asia Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Injectable Pain Medication Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Injectable Pain Medication Sales Value, 2019-2030
6.9.2 India Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
6.9.3 India Injectable Pain Medication Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Profile
7.1.2 GlaxoSmithKline Main Business
7.1.3 GlaxoSmithKline Injectable Pain Medication Products, Services and Solutions
7.1.4 GlaxoSmithKline Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.1.5 GlaxoSmithKline Recent Developments
7.2 Merck
7.2.1 Merck Profile
7.2.2 Merck Main Business
7.2.3 Merck Injectable Pain Medication Products, Services and Solutions
7.2.4 Merck Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.2.5 Merck Recent Developments
7.3 Pfizer
7.3.1 Pfizer Profile
7.3.2 Pfizer Main Business
7.3.3 Pfizer Injectable Pain Medication Products, Services and Solutions
7.3.4 Pfizer Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.3.5 Novartis Recent Developments
7.4 Novartis
7.4.1 Novartis Profile
7.4.2 Novartis Main Business
7.4.3 Novartis Injectable Pain Medication Products, Services and Solutions
7.4.4 Novartis Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.4.5 Novartis Recent Developments
7.5 Sanofi
7.5.1 Sanofi Profile
7.5.2 Sanofi Main Business
7.5.3 Sanofi Injectable Pain Medication Products, Services and Solutions
7.5.4 Sanofi Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.5.5 Sanofi Recent Developments
7.6 Bayer
7.6.1 Bayer Profile
7.6.2 Bayer Main Business
7.6.3 Bayer Injectable Pain Medication Products, Services and Solutions
7.6.4 Bayer Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.6.5 Bayer Recent Developments
7.7 Johson & Johson
7.7.1 Johson & Johson Profile
7.7.2 Johson & Johson Main Business
7.7.3 Johson & Johson Injectable Pain Medication Products, Services and Solutions
7.7.4 Johson & Johson Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.7.5 Johson & Johson Recent Developments
7.8 Boehringer Ingelheim
7.8.1 Boehringer Ingelheim Profile
7.8.2 Boehringer Ingelheim Main Business
7.8.3 Boehringer Ingelheim Injectable Pain Medication Products, Services and Solutions
7.8.4 Boehringer Ingelheim Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.8.5 Boehringer Ingelheim Recent Developments
7.9 Sun Pharmaceutical
7.9.1 Sun Pharmaceutical Profile
7.9.2 Sun Pharmaceutical Main Business
7.9.3 Sun Pharmaceutical Injectable Pain Medication Products, Services and Solutions
7.9.4 Sun Pharmaceutical Injectable Pain Medication Revenue (US$ Million) & (2019-2024)
7.9.5 Sun Pharmaceutical Recent Developments
8 Industry Chain Analysis
8.1 Injectable Pain Medication Industrial Chain
8.2 Injectable Pain Medication Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Injectable Pain Medication Sales Model
8.5.2 Sales Channel
8.5.3 Injectable Pain Medication Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Injectable Pain Medication Market Trends
    Table 2. Injectable Pain Medication Market Drivers & Opportunity
    Table 3. Injectable Pain Medication Market Challenges
    Table 4. Injectable Pain Medication Market Restraints
    Table 5. Global Injectable Pain Medication Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Injectable Pain Medication Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Injectable Pain Medication Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Injectable Pain Medication Product Type
    Table 9. Key Companies Time to Begin Mass Production of Injectable Pain Medication
    Table 10. Global Injectable Pain Medication Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Pain Medication as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Injectable Pain Medication Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Injectable Pain Medication Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Injectable Pain Medication Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Injectable Pain Medication Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Injectable Pain Medication Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Injectable Pain Medication Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Injectable Pain Medication Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Injectable Pain Medication Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Injectable Pain Medication Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Injectable Pain Medication Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Injectable Pain Medication Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Injectable Pain Medication Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Injectable Pain Medication Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Injectable Pain Medication Sales Value by Region (2019-2024) & (%)
    Table 27. Global Injectable Pain Medication Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Injectable Pain Medication Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Injectable Pain Medication Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Injectable Pain Medication Sales Value, (2025-2030) & (US$ Million)
    Table 31. GlaxoSmithKline Basic Information List
    Table 32. GlaxoSmithKline Description and Business Overview
    Table 33. GlaxoSmithKline Injectable Pain Medication Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Injectable Pain Medication Business of GlaxoSmithKline (2019-2024)
    Table 35. GlaxoSmithKline Recent Developments
    Table 36. Merck Basic Information List
    Table 37. Merck Description and Business Overview
    Table 38. Merck Injectable Pain Medication Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Injectable Pain Medication Business of Merck (2019-2024)
    Table 40. Merck Recent Developments
    Table 41. Pfizer Basic Information List
    Table 42. Pfizer Description and Business Overview
    Table 43. Pfizer Injectable Pain Medication Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Injectable Pain Medication Business of Pfizer (2019-2024)
    Table 45. Pfizer Recent Developments
    Table 46. Novartis Basic Information List
    Table 47. Novartis Description and Business Overview
    Table 48. Novartis Injectable Pain Medication Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Injectable Pain Medication Business of Novartis (2019-2024)
    Table 50. Novartis Recent Developments
    Table 51. Sanofi Basic Information List
    Table 52. Sanofi Description and Business Overview
    Table 53. Sanofi Injectable Pain Medication Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Injectable Pain Medication Business of Sanofi (2019-2024)
    Table 55. Sanofi Recent Developments
    Table 56. Bayer Basic Information List
    Table 57. Bayer Description and Business Overview
    Table 58. Bayer Injectable Pain Medication Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Injectable Pain Medication Business of Bayer (2019-2024)
    Table 60. Bayer Recent Developments
    Table 61. Johson & Johson Basic Information List
    Table 62. Johson & Johson Description and Business Overview
    Table 63. Johson & Johson Injectable Pain Medication Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Injectable Pain Medication Business of Johson & Johson (2019-2024)
    Table 65. Johson & Johson Recent Developments
    Table 66. Boehringer Ingelheim Basic Information List
    Table 67. Boehringer Ingelheim Description and Business Overview
    Table 68. Boehringer Ingelheim Injectable Pain Medication Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Injectable Pain Medication Business of Boehringer Ingelheim (2019-2024)
    Table 70. Boehringer Ingelheim Recent Developments
    Table 71. Sun Pharmaceutical Basic Information List
    Table 72. Sun Pharmaceutical Description and Business Overview
    Table 73. Sun Pharmaceutical Injectable Pain Medication Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Injectable Pain Medication Business of Sun Pharmaceutical (2019-2024)
    Table 75. Sun Pharmaceutical Recent Developments
    Table 76. Key Raw Materials Lists
    Table 77. Raw Materials Key Suppliers Lists
    Table 78. Injectable Pain Medication Downstream Customers
    Table 79. Injectable Pain Medication Distributors List
    Table 80. Research Programs/Design for This Report
    Table 81. Key Data Information from Secondary Sources
    Table 82. Key Data Information from Primary Sources
    Table 83. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Injectable Pain Medication Product Picture
    Figure 2. Global Injectable Pain Medication Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 4. Injectable Pain Medication Report Years Considered
    Figure 5. Global Injectable Pain Medication Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Injectable Pain Medication Revenue in 2023
    Figure 7. Injectable Pain Medication Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Picture
    Figure 9. Central Analgesics Picture
    Figure 10. Global Injectable Pain Medication Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Injectable Pain Medication Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospital
    Figure 13. Product Picture of Clinics
    Figure 14. Product Picture of Recovery Center
    Figure 15. Global Injectable Pain Medication Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Injectable Pain Medication Sales Value Market Share by Application, 2023 & 2030
    Figure 17. North America Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 18. North America Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
    Figure 19. Europe Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 20. Europe Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
    Figure 21. Asia Pacific Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 22. Asia Pacific Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
    Figure 23. South America Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 24. South America Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
    Figure 25. Middle East & Africa Injectable Pain Medication Sales Value (2019-2030) & (US$ Million)
    Figure 26. Middle East & Africa Injectable Pain Medication Sales Value by Country (%), 2023 VS 2030
    Figure 27. Key Countries/Regions Injectable Pain Medication Sales Value (%), (2019-2030)
    Figure 28. United States Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 29. United States Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 30. United States Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 31. Europe Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 32. Europe Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 33. Europe Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 34. China Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 35. China Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 36. China Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 37. Japan Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 38. Japan Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 39. Japan Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 40. South Korea Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 41. South Korea Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 42. South Korea Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 43. Southeast Asia Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 44. Southeast Asia Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 45. Southeast Asia Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 46. India Injectable Pain Medication Sales Value, (2019-2030) & (US$ Million)
    Figure 47. India Injectable Pain Medication Sales Value by Type (%), 2023 VS 2030
    Figure 48. India Injectable Pain Medication Sales Value by Application (%), 2023 VS 2030
    Figure 49. Injectable Pain Medication Industrial Chain
    Figure 50. Injectable Pain Medication Manufacturing Cost Structure
    Figure 51. Channels of Distribution (Direct Sales, and Distribution)
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS